Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Protein Biomarkers of Infertility Implicate Inflammation and Cell Growth/Remodeling Pathways.

JACC. Advances·2026
Same author

Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk.

Nature communications·2026
Same author

Mosaic Loss of Y chromosome associates with lung function, emphysema and epigenetic aging.

American journal of respiratory and critical care medicine·2026
Same author

Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program.

Atherosclerosis·2026
Same author

Plasma proteomics link menopause timing to brain aging and dementia risk.

medRxiv : the preprint server for health sciences·2026
Same journal

Interplay between genomic architecture alterations and GDF6 regulation: a candidate mechanism in Nablus mask-like facial syndrome.

HGG advances·2026
Same journal

Pediatric High-Grade Gliomas and Cancer Predisposition Syndromes: A Retrospective Study.

HGG advances·2026
Same journal

Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies eight risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21.

HGG advances·2026
Same journal

Expanding the ABCA2-associated neurodevelopmental phenotype.

HGG advances·2026
Same journal

A Pseudotime-Dependent TWAS Framework Identifies Disease Genes along Cell Developmental Paths.

HGG advances·2026
Same journal

A lethal form of ASCC3 disease: severe global developmental delay, axial hypotonia, hypoplasia of corpus callosum, hypothyroidism and micropenis.

HGG advances·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

An efficient LASSO framework for admixture-aware polygenic scores.

Franklin Ockerman1, Brian D Chen1, Quan Sun2

  • 1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

HGG Advances
|May 20, 2026
PubMed
Summary
This summary is machine-generated.

HAUDI improves polygenic scores (PGSs) for diverse populations by efficiently accounting for complex ancestry. This new method offers superior accuracy and speed compared to existing approaches for personalized medicine applications.

Keywords:
admixturelocal ancestrypolygenic scorespopulation geneticsstatistical genetics

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Related Experiment Videos

Last Updated: May 21, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Area of Science:

  • Genetics
  • Bioinformatics
  • Computational Biology

Background:

  • Polygenic scores (PGSs) are valuable for clinical applications but often perform poorly in non-European populations due to training data bias.
  • Existing cross-population PGS methods struggle with individuals of recent admixture, limiting their generalizability.
  • The GAUDI method addresses admixture but is computationally intensive and limited to two-way admixture.

Purpose of the Study:

  • To introduce HAUDI, an efficient LASSO-based framework for constructing polygenic scores in admixed populations.
  • To overcome the computational limitations and multi-way admixture constraints of the GAUDI method.
  • To enhance the accuracy and portability of PGSs across diverse ancestral backgrounds.

Main Methods:

  • HAUDI reparametrizes the GAUDI model into a standard LASSO problem for improved computational efficiency.
  • The framework is extended to accommodate multi-way admixture settings.
  • Performance was evaluated through extensive simulations and real-world data applications across 18 clinical phenotypes.

Main Results:

  • HAUDI demonstrates comparable or superior performance to GAUDI in simulations, with significantly reduced computation time.
  • In real data, HAUDI uniformly outperforms GAUDI across 18 clinical phenotypes, including triglycerides (TG), C-reactive protein (CRP), and mean corpuscular hemoglobin concentration (MCHC).
  • HAUDI shows substantial benefits over ancestry-agnostic PGSs for traits like white blood cell count (WBC) and chronic kidney disease (CKD), and outperforms SDPR_admix.

Conclusions:

  • HAUDI provides an efficient and accurate method for constructing polygenic scores in admixed populations.
  • The framework significantly improves PGS performance and generalizability across diverse ancestries.
  • HAUDI represents a substantial advancement for personalized medicine and genetic risk prediction in global populations.